glp-1 and depression GLP‑1 Depression: Can These Drugs Boost Mood? GLP-1 Agonists Can Be Heaven

1 CT-388 is an investigational once-weekly injectable therapy designed to reduce appetite and regulate blood glucose by selectively activating both GLP-1 and GIP receptors involved in energy homeostasis

Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation

February 2026 Compounded Semaglutide Pill Launch, DOJ Referral, and Withdrawal: In early February 2026, Hims announced the launch of a compounded semaglutide pill at $49 for the first month, roughly $100 less than Novo Nordisks newly approved Wegovy oral pill

The reason behind this is that they can enhance metabolic function, encourage fat export from the liver, and provide nutritional support